TruGraf Kidney
Commercial- Indications
- Kidney transplant rejection monitoring
Company intelligence / Profile preview
Eurofins Transplant Genomics
Mansfield, Massachusetts, United Statestransplantgenomics.com ↗
- Ownership
- Private
- Employees
- ~106
- Development stage
- Commercial
01
Overview
Eurofins Transplant Genomics develops and commercializes noninvasive molecular diagnostic tests—most notably the TruGraf blood gene expression assay—for early detection of graft injury and subclinical acute rejection in organ transplant recipients. Their technology enables personalized immunosuppression management to improve long-term graft survival. The company’s flagship product has received CMS approval for Medicare coverage in kidney transplants. They are part of the broader Eurofins network specializing in comprehensive pre-and post-transplant testing solutions.
- Therapeutic areas
- ImmunologyNephrology
- Modalities
- Diagnostic test (Molecular diagnostic)Biomarker-based diagnosticsGene expression assayNon-invasive blood test
- Industry
- Molecular Diagnostics
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Humana (national insurance coverage partnership for TruGraf)collaborations within the Eurofins group including Viracor, CellTX, Ascend Clinical.
Beyond the preview
Go deeper on Eurofins Transplant Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eurofins Transplant Genomics.